Medical specialty-related adherence to anti-osteoporotic regimens in fragility hip fracture patients.

about

Medical specialty-related adherence to anti-osteoporotic regimens in fragility hip fracture patients.

Item

http://www.wikidata.org/entity/Q38252857

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Medical specialty-related adhe ...... agility hip fracture patients.

@en

type

Item

label

Medical specialty-related adhe ...... agility hip fracture patients.

@en

prefLabel

Medical specialty-related adhe ...... agility hip fracture patients.

@en

P1476

Medical specialty-related adhe ...... agility hip fracture patients.

@en

P2093

Ching-Lan Chou

http://www.w3.org/2001/XMLSchema#string

Chung-Yuan Hsu

http://www.w3.org/2001/XMLSchema#string

Jia-Feng Chen

http://www.w3.org/2001/XMLSchema#string

Shan-Fu Yu

http://www.w3.org/2001/XMLSchema#string

Tien-Tsai Cheng

http://www.w3.org/2001/XMLSchema#string

Wen-Chan Chiu

http://www.w3.org/2001/XMLSchema#string

P2860

Adherence to Medication

Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture

Do patients receive recommended treatment of osteoporosis following hip fracture in primary care?

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

Zoledronic acid and clinical fractures and mortality after hip fracture.

Incidence and mortality of hip fractures in the United States

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

P2888

s00774-014-0621-7

P304

577-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00774-014-0621-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yu-Jih Su

P577

2014-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25240801

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis